The Respiratory Drug Delivery (RDD) conference returns to the US in 2024. Ideal for researchers, regulators, business professionals, and suppliers active in pulmonary and nasal drug delivery looking to learn more about inhalation drug delivery from experts in the field, RDD is the ideal international forum for those active in this field.
Integrating dedicated knowledge spaces presenting curated science and services by theme with podium presentations, posters, workshops and exhibitors, RDD ensures that information tailored to your areas of interest is easy to find.
Poster Presentation: Reducing Variability in the Inhaler Testing Environment
Authors: Ben Bradley, Dr Clair Brooks and Matthew Fenn
Workshop: Automating Orally Inhaled and Nasal Drug Product (OINDP) Testing: Lower Variability, Higher Productivity
Date: Tuesday 7th May
Join our Applications Specialist, Dr Clair Brooks, as she explores OINDP testing and automation’s role in addressing metered dose inhaler (MDI) reformulation challenges. Gain practical tips for implementing automation with Vertus® III+ and DecaVertus ® III to enhance productivity and reduce variability in OINDP testing data.
Workshop highlights:
- Navigating the evolving landscape of OINDP testing with a focus on automation benefits.
- Addressing challenges of MDI reformulation and nasal drug delivery testing.
- Discovering practical tips for implementing automation.
- Exploring the impact of uncontrolled variables on result integrity.
The 60-minute workshop will be repeated three times throughout the day to accommodate attendee preferences.
Copley looks forward to discussing the latest inhaler testing innovations, with our experts on hand to answer your OINDP testing questions during the workshop and also at our exhibitor table.
To find out more about the event and to register, please click here.
